L-165041
Cat. No.：YN290476
CAS No. ：79558-09-1
| 产品名称: | L-165041 |
| CAS No.: | 79558-09-1 |
| Chemical Name: | 2-[4-[3-(4-acetyl-3-hydroxy-2-propylphenoxy)propoxy]phenoxy]-acetic acid |
| Synonyms: | 2-(4-(3-(4-Acetyl-3-hydroxy-2-propylphenoxy)propoxy)phenoxy)acetic acid;L-165,041;2-(4-(3-(4-Acetyl-3-hydroxy-2-propylphenoxy)-propoxy)phenoxy)acetic acid;2-[4-[3-(4-acetyl-3-hydroxy-2-propylphenoxy)propoxy]phenoxy]acetic acid;4-[3-(4-ACETYL-3-HYDROXY-2-P |
| 分子量: | 402.44 |
| 分子式: | C₂₂H₂₆O₇ |
| SMILES: | O=C(O)COC(C=C1)=CC=C1OCCCOC2=CC=C(C(C)=O)C(O)=C2CCC |
| 存储: | Please store the product under the recommended conditions in theCertificate of Analysis. |
| 运输: | Room temperature in continental US; may vary elsewhere. |
| 产品描述: | L-165041 是一种细胞渗透的PPARδ激动剂，对 PPARδ 和 PPARγ 的Ki值分别为 6 nM 和 约 730 nM，可以在 NIH-PPARδ 细胞中诱导脂肪细胞分化。 |
| IC50和靶点: | [{name:"PPARδ:6 nM (Ki)"},{name: "PPARγ:730 nM (Ki)"}] |
| In Vitro: | |
| In Vivo: | |
| Clinical Trial: | |
| Solvent & Solubility: |
Berger, J., Leibowitz, M.D., Doebber, T.W., et al.Novel peroxisome proliferator-activated receptor (PPAR) γ and PPARδ ligands produce distinct biological effectsJ. Biol. Chem.274,6718-6725(1999)
Willson, T.M., Brown, P.J., Sternbach, D.D., et al.The PPARs: From orphan receptors to drug discoveryJ. Med. Chem.43(4),527-550(2000)
Porcelli, L., Gilardi, F., Laghezza, A., et al.Synthesis, characterization and biological evaluation of ureidofibrate-like derivatives endowed with peroxisome proliferator-activated receptor activityJ. Med. Chem.55(1),37-54(2012)
Basséne, C.E., Suzenet, F., Hennuyer, N., et al.Studies towards the conception of new selective PPARβ/δ ligandsBioorg. Med. Chem. Lett.16(17),4528-4532(2006)
Iwashita, A., Muramatsu, Y., Yamazaki, T., et al.Neuroprotective efficacy of the peroxisome proliferator-activated receptor δ-selective agonists in vitro and in vivoJ. Pharmacol. Exp. Ther.320(3),1087-1096(2007)
Leibowitz, M.D., Fiévet, C., Hennuyer, N., et al.Activation of PPARδ alters lipid metabolism in db/db miceFEBS Lett.473(3),333-336(2000)
